AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $14,017,000 | -25.8% | 499,000 | 0.0% | 0.46% | -19.3% |
Q2 2019 | $18,892,000 | -3.0% | 499,000 | 0.0% | 0.57% | -14.3% |
Q1 2019 | $19,471,000 | +232.1% | 499,000 | +81.5% | 0.67% | +157.7% |
Q4 2018 | $5,863,000 | -46.1% | 275,000 | 0.0% | 0.26% | -35.0% |
Q3 2018 | $10,887,000 | +3.6% | 275,000 | 0.0% | 0.40% | -8.3% |
Q2 2018 | $10,508,000 | +29.5% | 275,000 | +1.9% | 0.44% | +14.7% |
Q1 2018 | $8,114,000 | +15.4% | 270,000 | +20.0% | 0.38% | +3.5% |
Q4 2017 | $7,031,000 | +11.6% | 225,000 | 0.0% | 0.37% | +2.8% |
Q3 2017 | $6,302,000 | +46.4% | 225,000 | 0.0% | 0.36% | +33.2% |
Q2 2017 | $4,304,000 | +12.3% | 225,000 | 0.0% | 0.27% | +5.5% |
Q1 2017 | $3,834,000 | -6.7% | 225,000 | 0.0% | 0.25% | -4.9% |
Q4 2016 | $4,111,000 | +2.6% | 225,000 | 0.0% | 0.27% | +9.0% |
Q3 2016 | $4,007,000 | – | 225,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,806,832 | $34,582,764,000 | 27.20% |
Casdin Capital, LLC | 400,000 | $7,652,000 | 2.83% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,729,268 | $33,081,000 | 1.76% |
Redmile Group, LLC | 1,459,616 | $27,922,000 | 1.70% |
Opaleye Management Inc. | 150,000 | $2,869,000 | 1.20% |
Cormorant Asset Management, LP | 323,545 | $6,189,000 | 1.03% |
Orbimed Advisors | 4,801,638 | $91,855,000 | 0.96% |
Perceptive Advisors | 707,500 | $13,534,000 | 0.68% |
Rock Springs Capital Management LP | 595,200 | $11,386,000 | 0.58% |
SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $2,870,000 | 0.49% |